Hematologists Accepting Blue Cross Blue ShieldPage 5

Caron Jacobson, MD

Director, Immune Effector Cell Therapy Program; Senior Physician

Hematology

Mark Litzow, M.D.

Head, Acute Leukemia Group

Hematology

Alan Carlson, MD

Professor of Ophthalmology

Hematology

Hamed Daw, MD

Assistant Professor, Medicine, Case Western Reserve University School of Medicine

Hematology

Thomas Stinchcombe, MD

Professor of Medicine

Hematology

Rimas Lukas, MD

Professor, Feinberg School of Medicine

Hematology

Eric Winer, MD

Director, Adult Leukemia; Assistant Professor of Medicine, Harvard Medical School

Hematology

Christopher Flowers, M.D.

Division Head of Cancer Medicine and Chair, Department of Lymphoma-Myeloma

Hematology

Nancy Dawson, M.D.

Hematology

Reem Karmali, MD

Assistant Professor

Hematology

Pierluigi Porcu, M.D.

Professor of Medical Oncology; Division Director, Hematologic Malignancies; Program Leader, Immune Cell Regulation and Targeting, Sidney Kimmel Cancer Center at Thomas Jefferson University

Hematology

Philippe Armand, MD, PHD

Chief, Division of Lymphoma

Hematology

Aaron Logan, MD, PHD

Professor of Clinical Medicine

Hematology

Chau Dang, MD

Breast Medical Oncologist

Hematology

Dan Vogl, MD

Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

Hematology

Debasish Tripathy, M.D.

Professor of Medicine; Chair, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center

Hematology

Bhoomi Mehrotra, MD

Chair of Cancer Services for Catholic Health and Director of The Cancer Institute at St. Francis Hospital

Hematology

Gwynn Long, MD

Professor of Medicine

Hematology

Veronika Bachanova, MD

Section Head, Malignant Hematology and CAR-T Clinical Director

Hematology

Edward Garon, MD

Professor of Medicine, Division of Hematology/Oncology

Hematology